Focusing on respiratory disease this event will explore where digital health could have an impact in generating novel endpoints that give greater insight into disease progression and management. The keynote talk will be given by arm onEnabling Digital Health, with supporting talks from Owlstone Medical, Mologic and Pneumacare along with the finalists from the Digital Health Challenge.
Have you developed - or are you looking to create - a healthcare solution based on digital technology? If so, you stand the chance of winning £20,000 and mentoring opportunities from MedImmune - winners to be announced at this event. Details can be found in the attached flyer (see 'related document' near the Book Now button, above) or here.
Welcome and introduction
Jane Osbourn, Vice President, R&D, MedImmune
René van der Merwe, VP Clinical Respiratory, MedImmune
Keynote talk: Enabling Digital Health - ARM
Mobile technology is fully integrated into our daily lives; so how do we translate this into smart digital devices for proactive healthcare and pharmaceutical advancement? This presentation will challenge and discuss the barriers that exist to realizing the full benefits of patient connectivity at scale, and show how digital health will impact our not-so-distant future
Speaker: Peter Ferguson, Director of Healthcare Technologies
Breath Biopsy - VOCs biomarkers in early detection and precision medicine
Every time you breathe out there are thousand of chemicals on your breath called volatile organic compounds or VOCs. Some of these VOCs are biomarkers of disease in everything ranging from cancer to inflammatory and infectious disease. We'll discuss how Breath Biopsy technology can be used in early detection and precision medicine applications.
Speaker: Billy Boyle, Owlstone
The message in the bottle…….of urine!
Most of the biomarkers we find in urine originate in the lungs and are processed through the kidneys. Consequently, we can learn much about what’s going in the lungs and how the kidneys are responding to the presence of high levels of inflammatory mediators (including proteases) escaping from the lung into the blood. Mologic is busy developing ways to accurately determine the biomarker profiles by simple, patient-friendly technology, and to translate the resultant digital health data into simple diagnostic conclusions and triggering of interventions.
Speaker: Prof Paul Davis, Chief Scientific Officer
PneumaCare’s mission is to provide revolutionary imaging technologies that increase efficient and effective patient care with a vision of becoming the market leader in non-contact, non-invasive imaging technology.
PneumaCare is a Cambridgeshire (UK)-based company providing clinicians with unique non-invasive ways of observing active, real-time regional respiratory function via chest wall movement. It provides the capability for clinicians to assess respiratory function in all patients including previous inaccessible groups, whether young or old, conscious or unconscious, sitting or lying down; and its use does not require any contact or direct interaction with the patient.
Speaker: Paul Reynard, COO
The Digital Health Technology Challenge for Entrepreneurs
These entrepreneurs have a passion for creating novel digital solutions to solve drug development’s most difficult problems. Five finalists will have a chance to win the grand prize by presenting to a panel of prominent industry funding experts and executives:
- Jane Osbourn, Vice President, R&D, MedImmune
- Rene van der Merwe, Vice President, Clinical Development, MedImmune
- Andy Williams, Vice President, Strategy and Operations, AstraZeneca
- Debu Purkayastha, Managing Partner, 3rd Eye Capital
- Andrew Chapman, Digital Health Sector Lead, Digicatapult
To enter the awards:
Details to be advertised shortly: please email firstname.lastname@example.org
Q&A for the speakers
Closing remarks and the results of the Tech Challenge announced
Networking over light refreshments
You can follow @cambnetwork on Twitter.